General information

ICML welcomes you back in Lugano

The International Conference on Malignant Lymphoma (ICML) was first held in 1981 in Lugano, and since then it has never failed in providing an unique opportunity for the international community involved in the research and treatment of hematologic malignancies to share, debate and update their knowledge and expertise.

On behalf of the 17-ICML Organizing Committee and the Advisory Board, we are very proud to present the preliminary program of the next ICML, taking place in Lugano from June 13 to 17 2023. The Conference will take place in an in-person setting but a virtual participation will still be possible for those attendees who are unable to reach Lugano.

The program will address the state-of-the-art on the biology, pathology and management of lymphoid neoplasms. Sessions will include the extremely popular Clinical Case Discussions and Meet the Professor, in addition to general sessions, Focus-on and educational sessions.

We strongly encourage the submission of abstracts on all aspects of biology, pathology and treatment of lymphoid neoplasms, including CLL and multiple myeloma. All submitted abstracts will be evaluated and the best ones selected for oral or poster presentation with the help of our world-renowned reviewers.

More than ever, following the 2021 virtual edition, we look forward to welcoming the international lymphoma community once again in Lugano for another exciting ICML!

Franco Cavalli                    Francesco Bertoni

ICML President                  Organizing Committee Chairman


17-ICML Advisory Board

The Advisory Board gathers lymphoma experts and specialists from around the world. Their role is fundamental in the development of the ICML Scientific Program, helping the Organizing Committee to ensure not only the impartiality of the evaluation but also the multiplicity of approaches and skills.
They contribute to the choice of topics and speakers and evaluate the submitted abstracts. During the days of the Conference they collaborate by introducing special lectures and moderating the sessions.


Members of 17-ICML Advisory Board:

Ranjana H. Advani, Palo Alto, CA (USA)
James O. Armitage, Omaha, NE (USA) – Chairman
Helmut Beltraminelli, Locarno (Switzerland)
Elias Campo, Barcelona (Spain)
Bruce D. Cheson, Bethesda, MD (USA)
Nicholas Chiorazzi, Manhasset, NY (USA)
Wee Joo Chng, Singapore (Singapore)
Riccardo Dalla-Favera, New York, NY (USA)
Stephan Dirnhofer, Basel (Switzerland)
Martin Dreyling, Munich (Germany)
Jonathan W. Friedberg, Rochester, NY (USA)
Mary K. Gospodarowicz, Toronto, ON (Canada)
Peter W.M. Johnson, Southampton (UK)
Brad S. Kahl, St. Louis, MO (USA)
Won Seog Kim, Seoul (South Korea)
Marco Ladetto, Alessandria (Italy)
John P. Leonard, New York, NY (USA)
T. Andrew Lister, London (UK)

Stefano Luminari, Reggio Emilia (Italy)
Ari M. Melnick, New York, NY (USA)
Urban Novak, Bern (Switzerland)
Grzegorz S. Nowakowski, Rochester, MN (USA)
Koichi Ohshima, Kurume (Japan)
Astrid Pavlovsky, Buenos Aires (Argentina)
Leticia Quintanilla-Martinez de Fend, Tübingen (Germany)
Gilles Salles, New York, NY (USA)
Kerry J. Savage, Vancouver, BC (Canada)
John F. Seymour, Melbourne (Australia)
Lena Specht, Copenhagen (Denmark)
Catherine Thieblemont, Paris (France)
Wilhelm Wössmann, Hamburg (Germany)
Thorsten Zenz, Zurich (Switzerland)
Weili Zhao, Shanghai (China)
Pier Luigi Zinzani, Bologna (Italy)

Participant profile and congress objectives

The meeting objectives and learning outcomes are:

  • Acquaintance with the latest advances in basic science regarding lymphoma
  • Learning about recent results of translational research in lymphoma
  • Information on the most recent data from clinical studies
  • Fostering discussion and sharing of ideas among attendees about innovations in the field of lymphoma
  • Spreading evidence-based knowledge of primary clinical relevance

The content of the Program aims to:

  • Provide information that is useful to the work of participants and relevant to practice techniques
  • Present well-balanced data supported by adequate evidence
  • Allow time for discussion and questions

The last in-person ICML Congress (15-ICML, in 2019) gathered in Lugano about 3’500 physicians from all over the world: hematologists, clinical oncologists, radiation oncologists, pediatricians, pathologists and leading researchers involved in the study and treatment of lymphoid neoplasms.

Here are available the demographics of the 15-ICML and also of the 16-ICML, held virtually in 2021.


European School of Oncology (ESO)

The 17-ICML Program will be part of the sixth edition of the Certificate of Competence in Lymphoma (CCL), a 14-month European Credit Transfer and Accumulation System (ECTS) program developed by the European School of Oncology (ESO) and academically recognized by Ulm University.
The purpose of the Certificate of Competence is to provide a curriculum of studies to advance knowledge and science in the management of lymphoma patients.

For further information, please contact the ESO Bellinzona office.



The 17-ICML will take place at the Lugano Convention Centre, Palazzo dei Congressi, which is located in the city centre and overlooks the beautiful city park (Parco Ciani), on the shores of the lake of Lugano. The Convention Centre is 10-minute walk from the railway station. Its rooms will host general Scientific sessions and Satellite symposia.

Some of the sessions, for example, “Meet the Professor”, “Focus on...” and other parallel sessions, will be held in additional large conference rooms 5 minutes' walk from the main Convention Centre (Cinema Corso and USI, Università della Svizzera italiana). The same rooms will also serve as overflow areas for the main sessions, which will be held at the Palazzo dei Congressi.

Lunches, coffee breaks and the commercial Exhibition will all take place in the “Marquee Parco Ciani”, a large gazebo, overlooking the lake and connected to the Palazzo dei Congressi by a covered walkway. The Marquee will also host the Poster session and an additional overflow area.


On-site health safety measures

There are currently no pandemic measures in place in Switzerland and no entry restrictions are applied. 
Hand sanitizing stations will be available on-site to ensure a cleaner Conference environment.

Please visit the following links for more information:


Climate conscious event

17-ICML is committed to being a “climate conscious event”.
To partially compensate for the C02 emissions caused by our Conference and to combat climate change, ICML is proud to partner once again with South Pole, a leading project developer and global climate solutions provider supporting more than 700 projects aiming at reducing carbon emissions and protect biodiversity.

In particular, 17-ICML will support the “Envira Amazonia Tropical Forest Conservation in Brazil” project, whose goal is to protect the rainforest from logging and encroaching cattle ranches in order to preserve the area’s rich biodiversity and mitigate the C02 emissions. The project also promotes environmental stewardship and supports health services and educational courses for the local community.